Skip to main content
. Author manuscript; available in PMC: 2013 May 1.
Published in final edited form as: Neurogenetics. 2012 Mar 25;13(2):133–140. doi: 10.1007/s10048-012-0318-9

Table 2.

Clinical rating scale scores of affected HDL2 patients assessing motor and cognitive function

Subject III.1 III.2 III.6 III.13 III.14 IV.2
UPDRS motor score 54 29 76 91 34 17
UHDRS motor score (I) 65 45 80 94 40 22
UHDRS chorea subscore 3 7 0 4 3 5
UHDRS cognitive score (II) NA 158 NA NA 56 270
Verbal fluency test NA 9 NA NA NA 45
Stroop test NA 42-62-28 NA NA 26-30-NA 64-90-22
Symbol digit modalities test NA 17 NA NA NA 49
UHDRS behavioral score (III) NA 19 NA NA 0 20
UHDRS functional score (IV) 7 11 0 0 12 25
UHDRS independence score (V) 55 65 50 20 70 100
UHDRS functional capacity scale (VI) 3 5 2 0 0 13
MMSE NAa 19 NA NA 7 24b

UPDRS = United Parkinson disease rating scale motor score (possible range, 0 –108); UHDRS parts I and III, higher scores are associated with more advanced disease; UHDRS parts II, IV, V and VI, lower scores are associated with more advanced disease. UHDRS = United Huntington disease rating scale motor score (I) has a range of 0 –124; UHDRS chorea subscore = chorea-relevant motor score of the UHDRS, i.e. item 12a–g (possible range, 0–28); MMSE = Mini Mental State Examination; NA, test results could not be acquired secondary to mutism and/or severe dementia.

a

18 months prior, MMSE = 8; 12 months prior, MMSE = 10.

b

7 months prior, MMSE =27.